Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines: Non-Small Cell Lung Cancer, Version 2.2021

  • David S. Ettinger
  • , Douglas E. Wood
  • , Dara L. Aisner
  • , Wallace Akerley
  • , Jessica R. Bauman
  • , Ankit Bharat
  • , Debora S. Bruno
  • , Joe Y. Chang
  • , Lucian R. Chirieac
  • , Thomas A. D'Amico
  • , Thomas J. Dilling
  • , Jonathan Dowell
  • , Scott Gettinger
  • , Matthew A. Gubens
  • , Aparna Hegde
  • , Mark Hennon
  • , Rudy P. Lackner
  • , Michael Lanuti
  • , Ticiana A. Leal
  • , Jules Lin
  • Billy W. Loo, Christine M. Lovly, Renato G. Martins, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip P. Patel, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda Tam, Jane Yanagawa, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes

Research output: Contribution to journalReview articlepeer-review

845 Scopus citations

Fingerprint

Dive into the research topics of 'Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines: Non-Small Cell Lung Cancer, Version 2.2021'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science